Phenom, an AI company specializing in HR, announced 42 additions to its rapidly expanding IAMPHENOM 2025 speaker lineup — ...

Joseph W. Mattia, a lifelong resident of Braintree, peacefully passed away on February 9, 2025. A beloved husband, father, brother, and uncle, he will be leaving behind a long legacy of love and ...

NEW YORK/FRANKFURT, Feb 10 (Reuters) - (This Feb. 10 story has been refiled to say 'LOEs (loss of exclusivity),' not 'LOEs (levels of evidence),' in paragraph 13) Merck, in a statement ...

Surprisingly, only Mattia Bellucci remains among the Italians competing at the ATP in Rotterdam. After the eliminations of Cobolli, Berrettini, Sonego, and Vavassori, and Sinner's absence ...

Mattia Preti, the very prolific baroque painter of the 17th century, is certainly very well-known in Malta where he spent the last 40 years of his life and where he produced hundreds of paintings ...

Here’s how it works. Mattia Agostinacchio claimed the junior men's title for Italy at the 2025 Cyclo-cross World Championships in Liévin after a gripping battle with France's Soren Bruyère ...

Merck’s stock tumbled 11.8% Tuesday, putting it on track for its biggest one-day selloff in almost 17 years, after the drug company’s softer-than-expected guidance amid struggles for its HPV ...

Merck on Tuesday missed earnings estimates, lowered its guidance for this year’s earnings, and withdrew a target for sales of its HPV vaccine, Gardasil, to reach $11 billion by 2030. The result ...

Merck’s Q4 sales rose 7% YoY to $15.62B, slightly beating the $15.49B consensus. Adjusted EPS jumped to $1.72, topping estimates of $1.62. Keytruda sales grew 19% YoY to $7.84B, while Gardasil ...

Shares of global pharmaceutical company Merck (NYSE:MRK) fell 11% in the morning session after the company reported mixed fourth-quarter earnings. Its full-year revenue and EPS guidance missed by ...

Merck’s MRK fourth-quarter revenue grew 7% to $15.6 billion (including Keytruda growth of 21% to $7.8 billion), in line with overall 7% growth for the year. Shares fell more than 10% as Merck ...

Merck (MRK) reported fourth quarter and full-year earnings Tuesday, in line with Wall Street estimates. The bad news: Its stock was down more than 10% in early trading, largely because of weaker ...